HealthEquity (HQY) Tops Q1 EPS by 7c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Oil rally pressures S&P, Nasdaq; Microsoft, Salesforce buoy Dow
- Oil prices rise 2% as attacks on Saudi Arabia overshadow Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
- One dead in new attack on Saudi airport, a day after Houthi strike kills 13
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- Lumentum shares fall after hitting 52-week high
- Stryker invests $400M in CMR Surgical with option to acquire
HealthEquity, Inc (HQY) PT Raised to $55 at Cantor Fitzgerald
June 7, 2017 6:59 AM EDTCantor Fitzgerald raised its price target on HealthEquity, Inc (NASDAQ: HQY) to $55.00 (from $50.00) while maintaining a Overweight rating.
Analyst Steven Halper raises his PT following "solid" Q1 2018 results. His confidence increases for his medium-term growth estimates and see further opportunity for the... More
HealthEquity, Inc (HQY) PT Raised to $57 at Chardan Capital Markets; 'Strong Execution'
June 7, 2017 6:04 AM EDTChardan Capital Markets raised its price target on HealthEquity, Inc (NASDAQ: HQY) to $57.00 (from $53.00) while maintaining a Buy rating.
Analyst Steven Wardell notes Q1 adj. EBITDA was in-line with expectations and a 1% topline beat driven by strong performance in the Custodial revenue.... More



